Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer

被引:0
作者
Kokoro Kobayashi
Yoshinori Ito
Masaaki Matsuura
Ippei Fukada
Rie Horii
Shunji Takahashi
Futoshi Akiyama
Takuji Iwase
Yasuo Hozumi
Yoshikazu Yasuda
Kiyohiko Hatake
机构
[1] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Breast Medical Oncology
[2] Cancer Institute of Japanese Foundation for Cancer Research,Division of Cancer Genomics
[3] and Bioinformatics Group,Department of Pathology
[4] Genome Center of Japanese Foundation for Cancer Research,Department of Pathology
[5] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Breast Surgical Oncology
[6] The Cancer Institute of the Japanese Foundation for Cancer Research,Department of Breast Oncology
[7] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gastrointestinal Surgery
[8] Jichi Medical University,Department of Hematology and Oncology
[9] Jichi Medical University,undefined
[10] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,undefined
来源
Surgery Today | 2016年 / 46卷
关键词
Intrinsic subtype; Luminal; Triple negative; HER2; Metastatic breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:821 / 826
页数:5
相关论文
共 142 条
[1]  
Jemal A(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96
[2]  
Siegel R(2011)Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project Jpn J Clin Oncol 41 139-147
[3]  
Ward E(2005)(EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717
[4]  
Hao Y(1998)Treatment of breast cancer N Engl J Med 339 974-984
[5]  
Xu J(2007)The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer Cancer 110 973-979
[6]  
Murray T(2009)Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995–2005 Onkologie 32 107-113
[7]  
Matsuda T(2004)Is breast cancer survival improving? Cancer 100 44-52
[8]  
Marugame T(2005)Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies Cancer 104 1742-1750
[9]  
Kamo K(2011)Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 1736-1747
[10]  
Katanoda K(2013)Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol 24 2206-2223